<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-pharmaceuticals-12-00060">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yockey</surname>
    <given-names>L.J.</given-names>
   </name>
   <name>
    <surname>Jurado</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Arora</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Millet</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rakib</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Milano</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Hastings</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Fikrig</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Horvath</surname>
    <given-names>T.L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Type I interferons instigate fetal demise after Zika virus infection</article-title>
  <source>Sci. Immunol.</source>
  <year>2018</year>
  <volume>3</volume>
  <fpage>eaao1680b</fpage>
  <pub-id pub-id-type="doi">10.1126/sciimmunol.aao1680</pub-id>
  <pub-id pub-id-type="pmid">29305462</pub-id>
 </element-citation>
</ref>
